These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The treatment targets of asthma: from laboratory to clinic. Fang C; Corrigan CJ; Ying S Inflamm Allergy Drug Targets; 2008 Jun; 7(2):119-28. PubMed ID: 18691142 [TBL] [Abstract][Full Text] [Related]
3. Mechanopharmacology of Rho-kinase antagonism in airway smooth muscle and potential new therapy for asthma. Wang L; Chitano P; Seow CY Pharmacol Res; 2020 Sep; 159():104995. PubMed ID: 32534100 [TBL] [Abstract][Full Text] [Related]
4. Rho-kinase inhibition attenuates airway responsiveness, inflammation, matrix remodeling, and oxidative stress activation induced by chronic inflammation. Possa SS; Charafeddine HT; Righetti RF; da Silva PA; Almeida-Reis R; Saraiva-Romanholo BM; Perini A; Prado CM; Leick-Maldonado EA; Martins MA; Tibério Ide F Am J Physiol Lung Cell Mol Physiol; 2012 Dec; 303(11):L939-52. PubMed ID: 23002076 [TBL] [Abstract][Full Text] [Related]
5. Rho kinase as a therapeutic target in the treatment of asthma and chronic obstructive pulmonary disease. Fernandes LB; Henry PJ; Goldie RG Ther Adv Respir Dis; 2007 Oct; 1(1):25-33. PubMed ID: 19124345 [TBL] [Abstract][Full Text] [Related]
6. RhoA/Rho-kinase as a therapeutic target in asthma. Kume H Curr Med Chem; 2008; 15(27):2876-85. PubMed ID: 18991642 [TBL] [Abstract][Full Text] [Related]
7. Targeting abnormal airway vascularity as a therapeutical strategy in asthma. Park HS; Kim SY; Kim SR; Lee YC Respirology; 2010 Apr; 15(3):459-71. PubMed ID: 20337993 [TBL] [Abstract][Full Text] [Related]
9. Rho-kinase as a drug target for the treatment of airway hyperrespon-siveness in asthma. Gosens R; Schaafsma D; Nelemans SA; Halayko AJ Mini Rev Med Chem; 2006 Mar; 6(3):339-48. PubMed ID: 16515473 [TBL] [Abstract][Full Text] [Related]
10. Anti-remodelling drugs for the treatment of asthma: requirement for animal models of airway wall remodelling. Fernandes DJ; Xu KF; Stewart AG Clin Exp Pharmacol Physiol; 2001 Aug; 28(8):619-29. PubMed ID: 11473527 [TBL] [Abstract][Full Text] [Related]
11. Selective targeting of CREB-binding protein/β-catenin inhibits growth of and extracellular matrix remodelling by airway smooth muscle. Koopmans T; Crutzen S; Menzen MH; Halayko AJ; Hackett TL; Knight DA; Gosens R Br J Pharmacol; 2016 Dec; 173(23):3327-3341. PubMed ID: 27629364 [TBL] [Abstract][Full Text] [Related]
12. Role of human airway smooth muscle in altered extracellular matrix production in asthma. Johnson PR Clin Exp Pharmacol Physiol; 2001 Mar; 28(3):233-6. PubMed ID: 11236132 [TBL] [Abstract][Full Text] [Related]
13. Airway smooth muscle as an immunomodulatory cell: a new target for pharmacotherapy? Lazaar AL; Panettieri RA Curr Opin Pharmacol; 2001 Jun; 1(3):259-64. PubMed ID: 11712749 [TBL] [Abstract][Full Text] [Related]
14. Airway remodeling in asthma and irreversible airflow limitation-ECM deposition in airway and possible therapy for remodeling-. Yamauchi K; Inoue H Allergol Int; 2007 Dec; 56(4):321-9. PubMed ID: 17965575 [TBL] [Abstract][Full Text] [Related]
15. Airway remodelling in asthma and novel therapy. Manuyakorn W; Howarth PH; Holgate ST Asian Pac J Allergy Immunol; 2013 Mar; 31(1):3-10. PubMed ID: 23517388 [TBL] [Abstract][Full Text] [Related]
17. Asthma therapy: how far have we come, why did we fail and where should we go next? Janssen LJ Eur Respir J; 2009 Jan; 33(1):11-20. PubMed ID: 19118224 [TBL] [Abstract][Full Text] [Related]
18. Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. Holgate ST; Peters-Golden M; Panettieri RA; Henderson WR J Allergy Clin Immunol; 2003 Jan; 111(1 Suppl):S18-34; discussion S34-6. PubMed ID: 12532084 [TBL] [Abstract][Full Text] [Related]
19. Airway remodelling and inflammation in asthma are dependent on the extracellular matrix protein fibulin-1c. Liu G; Cooley MA; Nair PM; Donovan C; Hsu AC; Jarnicki AG; Haw TJ; Hansbro NG; Ge Q; Brown AC; Tay H; Foster PS; Wark PA; Horvat JC; Bourke JE; Grainge CL; Argraves WS; Oliver BG; Knight DA; Burgess JK; Hansbro PM J Pathol; 2017 Dec; 243(4):510-523. PubMed ID: 28862768 [TBL] [Abstract][Full Text] [Related]
20. Ovalbumin-induced allergic inflammation lead to structural alterations in mouse model and protective effects of intranasal curcumin: A comparative study. Subhashini ; Chauhan PS; Singh R Allergol Immunopathol (Madr); 2016; 44(3):246-56. PubMed ID: 27046748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]